Identification and counseling for obesity among children on psychotropic medications in ambulatory settings

The Association of BMI Status With Adolescent Preventive Screening

(2011) C. B. Jasik et al.   PEDIATRICS

Screening for Obesity-Related Complications Among Obese Children and Adolescents: 1999–2008

(2010) Lacey J. Benson et al.   Obesity

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Metabolic profiles of second-generation antipsychotics in early psychosis: Findings from the CAFE study

(2009) Jayendra K. Patel et al.   SCHIZOPHRENIA RESEARCH

Metabolic and Cardiovascular Adverse Events Associated With Antipsychotic Treatment in Children and Adolescents

(2008) Roger S. McIntyre et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Clozapine Versus “High-Dose” Olanzapine in Refractory Early-Onset Schizophrenia: An Open-Label Extension Study

(2008) Sanjiv Kumra et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Primary care physicians' knowledge, attitudes, beliefs and practices regarding childhood obesity: a systematic review

(2008) M. van Gerwen et al.   Obesity Reviews

Trends in the Diagnosis of Overweight and Obesity in Children and Adolescents: 1999-2007

(2008) L. Benson et al.   PEDIATRICS

Adequacy of two ambulatory care surveillance systems for tracking childhood obesity practice patterns

(2008) Ihuoma U. Eneli et al.   PUBLIC HEALTH